Professional Documents
Culture Documents
Chief complaint
Patient: C.P.
52-year-old
Male
Experiencing chest pain
Radiating to his left arm and jaw
Uninsured
background
Full-time construction worker
Four children
Past episodes of chest tightness with exertion
the past six months
first visit to the ED
Surgical history:
total cholecystectomy 10 years ago
Emergency department
12 lead ECG
hyper acute ST elevation
anterior, lateral and inferior leads
Na
135 mmol/L
3.0 mmol/L
Co2
28
Cl
101 mEq/L
BUN
12 mg/dL
Glucose
165
Ca
10.1
Creatinine
2.8 mg/dL
CPK
12.4 ng/ml
HCO3
18 mmol/L
ABG
PaO2 86
PaCO2 35
Bicarb 24
WBC
14.5
Hgb
8.5 g/dL
Hct
35.3%
INR
3.9
Hgb A1C
7.0
pH
7.30
Priority action
Put on cardiac monitor immediately
Support ABCs
Notify the MD
Have the code cart ready
Be prepared for CPR and/ or defibrillation
Know that rapid reperfusion is the priority
when a client is experiencing a STEMI we
would start to prep the client for the cath lab.
additional actions
Put on 2L O
Give 325 mg aspirin
Insert 2 large bore IVs (20 or better)
Give Nitro
Systolic should be greater than 100 before
administering Nitro
Evaluate VS Q 15 min
Portable chest X-Ray within 30 minutes
Immediate concerns
Reperfusion
Maintaining BP (ABCs)
Need to obtain:
Troponin
Magnesium
update
During interview C.P. reports:
Worsening chest discomfort
Morphine sulfate
Nursing considerations:
Solution is colorless; do not administer
discolored solution.
Dilute with at least 5 mL of sterile water 0.9%
NaCl for injection
Concentration: 0.5-5 mg/mL
Rate: Administer over 5 min. Rapid
administration may lead to increased
respiratory depression, hypotension, and
circulatory collapse.
Nursing interventions
Morphine Sulfate
Assess type, location, and intensity of pain prior
to and 20 min after IV
High Alert!! Assess level of consciousness, BP,
pulse, and respirations before and periodically
during administration. If RR is <10/min, assess
level of sedation. Physical stimulation may be
sufficient to prevent significant hypoventilation.
Advise patient to change position slowly to
minimize orthostatic hypotension.
update
Troponin interpretation
Elevated serum enzyme levels are the result
of the necrosis from the MI
Troponin T > or = to 0.01 are at increased risk
for cardiac events.
His was at .20
Puts him at greater risk for cardiac events.
Admitting diagnosis
st elevations on ECG
Ecg description to
patient
ST elevation
indicates lack
of oxygen to
the muscle
tissue of your
heart.
Myocardium areas
Anterior lead= left anterior descending coronary
artery (LAD)
Administer TPA?
NO!
C.P. INR value= 3.9 seconds (too high)
Puts patient at risk for bleeding
Administration contraindicated INR>1.7
seconds
TPA indications
ST elevations
Timeframe
Tpa contraindications
Absolute
Hemorrhagic stroke
Ischemic stroke within 6
mos.
Recent trauma to the
head
Aortic dissection
Major GI bleed
Known bleeding
disorder
Relative
Hypertension systolic
>180
Oral anticoagulation
therapy
Traumatic resuscitation
Non compressible
puncture sites
Active peptic ulcer
Dosage
Total 100mg IV
60 mg over 1st hr
20 mg over the 2nd hr
20 mg over the 3rd
Usually accompanied by heparin therapy
Nursing interventions
Monitor VS including temperature
Continuous or Q4 hours
Do not use lower extremities to monitor BP
Notify HCP:
systolic >180 mmHg or diastolic >110mmHg
Hypotension occurs
Result from drug, hemorrhage, or cardiogenic
shock
Rash
Dyspnea
Fever
Changes in facial color
Swelling around the eyes
Wheezing
Risks
Hypersensitivity reaction
Frank bleeding may occur
Invasive procedure sites
Body orifices
Internal bleeding
Decreased neurological status
Abdominal pain
Coffee-ground emesis or black tarry stools
Hematuria
Joint pain
Stroke
Concerns
Long term:
Extending the MI
Chance of the patient coding
Short term:
Contraindicated with anticoagulants
When did the symptoms onset
Clinical symptoms
TPA
Epistaxis
Bronchospasm
Hemoptysis
Reperfusion arrhythmias
Hypotension
N/V
Flushing
Phlebitis at injection site
Fever
UPDATE
C.P taken to cardiac catheterization lab for
further evaluation and intervention.
Part of tx intractable chest pain
Pre-procedure
responsibilities
Prior to cardiac catheterization lab
Informed consent
Reinforce teaching
Shave/prep the groin
Establish two peripheral venous access sites.
Specimens for lab tests
Chest x-ray
EKG/ECG, baseline vascular observations
Pre-op responsibility
Monitor
PTT
INR
CBC with differential
PTCA
Nurses explanation
Patient:
Panicked
Urgent situation
Nurse:
UPDate
C.P
Pain free
Brief V.fib
Defibrillated two
times
Currently NSR
PTCA
3 non medicated
stents
Update cont.
Strong pulses bilaterally
AAOx3
O2 sat 96% RA
BP 90/58
HR 60
RR 18
Pulse ox 92%
Additional assessment
Neurological status
Signs of bleeding
Frank/internal
Additional assessment
cont.
Inspect insertion site
Color, warmth, sensation, movement
Distal pulse
Place mark on sites
Vascular observations
Q 15min first 2 hours
Hourly remaining 6 hours
Post-Op complications
Chest pain
Ischemic chest pain similar to prior pain
Pericarditic chest pain
Inflammation of pericardium
Mainstay treatment
Analgesia- NSAIDs
Possible Post-Op
complications
Renal impairment
Contrast induced nephropathy
Particularly pre-existing renal failure, diabetic
neuropathy and older patients
Post-op complications
Bleeding
Aggressive anti-platelet and anti-thrombotic
therapies
Contact HCP:
Swelling
Blood loss
Tenderness around access site
Post-op complications
Pseudoaneurism
Considered in any patient with a hematoma
Artery fails to close
Pulsatile swelling
Pain on palpitation
Analgesia and atropine
update
Unequal pulses in LE
Weak pedal pulses right side
Large hematoma right groin
Post PTCA
Nursing interventions:
Bed-rest 4-6 hours
Prevent bleeding at insertion site
Asses
Vital signs
Delayed allergic reactions
Rash, tachycardia, hypertension, palpitations, N/V
Extremities
signs of ischemia, no distal pulse
Insertion site
Bleeding, inflammation, hematoma
Post PTCA
Nursing interventions:
Education
Resume usual diet, fluids, medications, activity
Observe insertion site
Cold compresses to puncture site
Bed rest 4-6 hours afterwards
Report to provider
Pleuritic pain, persistent right shoulder pain,
abdominal pain
Post PTCA
Positioning
Legs in abduction/ parallel
Lay flat HOB no higher 30
Affected extremity kept straight
4-6 hours
Additional labs
Monitor PTT
Monitor platelet count Potassium (may cause
hyperkalemia)
AST and ALT levels (may increase)
UAP delegation
Vital signs q15 min(4), every 30min(2), and
every 60 min(2): Report Systolic BP under 90
Check stool to monitor signs of bleeding
Assist patient with ADLs and positioning: he
must lay flat to prevent bleeding from incision
site
If Nursing Assistant is skilled, have her attach
patient to ECG machine
Which Pharmaceutical
treatments would you
give C.p. ?
Nitroglycerin
Lidocaine
Dopamine
Metroprolol
Aspirin
And heparin
Medications to
administer
Dopamine: vasopressor/adrenergic, increases cardiac output,
increases BP,
contraindicated in: tachyarrhytmias, pheochromocytoma, and
hypersensitivity
Use cautiously in: hypovolemia, myocardial infarction, occlusive
vascular diseases
Interdisciplinary care
Potassium supplementation
Echocardiogram post cath
Dietary
Diabetes education
Weight loss/ nutrition counseling
Occupational Therapy
Smoking cessation- alcohol awareness r/t CAD
Case worker: health insurance
Update
During his PTCA procedure, a circumflex
coronary artery lesion was found
The PTCA failed in that artery and a stent was
inserted
He remains on lidocaine and dopamine drips
VS are now stable and PCWP is 20mmHg, and
CO is 7.3L/min
Lidocaine
Lab results for Patients licocaine level is 2.5 m/ml
Lidocaine therapeutic levels are between 1.5-5.0
mcq/ml
Toxicity:
Confusion, excitation, blurred vision,
nausea/vomiting, tinnitus, tremors, twitching,
seizures, dyspnea, dizziness, fainting, decreases
heart rate
If occurs, stop infusion, notify the provider and
monitor the patient
Update
C.P. is becoming increasingly anxious
Stent was successful and he is stable and
present at the time
While continuing to monitor
- C.P. suddenly becomes faint, immediately
loses consciousness and becomes pulseless
and apneic
- No BP, and heart sounds are absent
Additional steps
Nurses need to communicate to one another and
determine who is leading the code, obtaining
emergency code medications and administering
Be prepared to switch roles for CPR
Have the code cart available
Be prepared to give code meds
Be prepared for intubation
Room needs to be free of clutter, and patient
needs to be easily accessible
Update
The patient is in full cardiac arrest and CPR is
in progress.
The ECG monitor shows PEA.
What is the priority nursing intervention for
this patient?
5 Ts
Tension
pneumothorax
Tamponade, cardiac
Toxins
Thrombosis,
pulmonary
Thrombosis, coronary
Update
The family is asking to be present in the room
during CPR.
Should this request be honored?
Will we be performing
defibrillation on this
patient?
Defibrillator Charge
Biphasic
Monophasic
Initial dose of
120-200 J
Second and
subsequent
doses should be
equivalent or
higher .
360 J
Epinephrine
(Adrenalin)
Indication: Part of ACLS
guidelines for the
management of cardiac
arrest
Action:
Affects both beta
(cardiac)-adrenergic
receptors and beta
(pulmonary)-adrenergic
receptor sites
Alpha-adrenergic agonist
properties, which result
in vasoconstriction
Produces bronchodilation
Vasopressin
(Pitressin)
Indication: Management
of PEA
Action:
Alters the
permeability of the
renal collection ducts,
allowing reabsorption
of water
Directly stimulates
musculature of the GI
tract
In high doses acts as
a nonadrenergic
peripheral
vasoconstrictor
Vasopressin
(Pitressin)
IV push
1 mg q 3-5
minutes
IV push
40 units as a single
dose
Can replace first or
second dose of
epinephrine
family support
Offer comfort and
support.
Update
The CODE BLUE was ended after 30 minutes of
ACLS interventions.
nurse's responsibility
Clear all medical equipment and supplies out of the
room, cover the patient from the neck down, and make
the environment comfortable for the family to mourn
Listen, answer questions, and provide support for the
family
Ensure they understand everything that was done to
try and save their loved one
Provide referrals
Post mortem care